The treatment for diabetic eye diseases, either for diabetic maculopathy or diabetic retinopathy has been revolutionized in the last five years. Primarily for maculopathy due to the development of injections into the eye, into the vitreous cavity of the eye, the area in front of the retina.
The mainstay of treatment used to be laser treatments – with these laser treatments resulting in variable degrees of retinal destruction. So, they are often associated with a degree of visual loss. Also the effect from laser treatment takes some time to be noticed by patients. We are now in the era where diabetic eye disease is predominantly managed with injections into the eye. We have three different injections that we can use and the responses far exceed those that we see with laser treatment.
Professor Michel Michaelides is a Professor of Ophthalmology at Clinica London. His special expertise is in Retinal Diseases, including Inherited Retinal Diseases, Age Related Macular Degeneration, Diabetic Retinopathy and Maculopathy, and Retinal Vein Occlusions.
He has over 16 years experience in treating people with eye problems just like you, and has published extensively in scientific journals about diabetic eye disease, age-related macular degeneration and inherited eye disease, and also lead multiple clinical trials investigating novel therapies. At Clinica London, he is responsible for Retinal Diseases both in adults and children.